WE KNOW HOW TO TELL IT

Houston, TX

Alzeca is focused on developing novel targeted MRI imaging agents for the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. The company’s proprietary technology is based on nanoparticles that specifically bind to abnormal proteins that accumulate in the brain years before significant cognitive symptoms appear.

Houston, TX
 

Aravive is developing novel cancer therapeutics that spare healthy cells while targeting tumor adaptive responses and cancer evasion pathways. The company's primary therapeutics focus is the GAS6-AXL pathway, which can interrupt oncogenic signals and turn off the "survival switch" that allows cancer to grow, spread and acquire therapeutic resistance.

Paris, France

Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.

Vancouver, WA

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. Their lead product candidate, Pro140, is the first self-administered antibody in late-stage clinical trials and works by blocking HIV from entering cells.

Sunnyvale, CA

Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.

Austin, TX

Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.

Emeryville, CA

Founded by physicists from the University of California-Berkeley and Lawrence Berkeley National Laboratory, Nanōmix is developing the next generation of mobile, point-of-care medical diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. .

Wellesley, Mass and Reston, VA

Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.

Menlo Park, CA

Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the
design, development and commercialization of innovative tools
for biological research.

Redwood City, CA

Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.

Beverly, MA

Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.

Stamford, CT

Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics.

Grand Rapids, MI

Tetra Discovery Partners is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, traumatic brain injury, major depression and schizophrenia. Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

Santa Cruz, CA

Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling sophisticated laboratory equipment.

Allakos • Association for Molecular Pathology • Applied Biosystems • BD Biosciences
Benchling • Biotique Systems • Cellular Research • Chiron Corporation • Connetics • Cynvenio Biosystems • DNAnexus • DoubleTwist • Eos • Eurofins Genomics • Gen9
GE healthymagination • Genentech • GenoSpectra • IntegenX • Invitrogen • Medcision • Microsoft Health Solutions • Medtronic • Mohr Davidow Ventures • NanoString Technologies • Nektar Omicia • Osel • PAG • PaxVax • Personalis • Protagonist • RainDance Technologies • StationX • Varian Medical Systems • VitaPath Genetics • Zyomyx